Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,134 public trials 1,863 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

NCT07459634

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • Valkyrie Clinical Trials, Inc. Los Angeles, California, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Carolina Blood and Cancer Care Rock Hill, South Carolina, United States
View Trial Details
Recruiting

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

NCT07190248

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Central Alabama Research ( Site 0108) Birmingham, Alabama, United States
  • Stamford Hospital ( Site 0126) Stamford, Connecticut, United States
  • Mount Sinai Cancer Center ( Site 0137) Miami Beach, Florida, United States
  • New England Cancer Specialists ( Site 0139) Westbrook, Maine, United States
View all 211 locations
View Trial Details
Recruiting

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

NCT07325136

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Duke Cancer Institute Durham, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 13 locations
View Trial Details
Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

NCT07218146

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of California San Diego La Jolla, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Yale Cancer Center/Clinical Trials Office New Haven, Connecticut, United States
View all 155 locations
View Trial Details
Recruiting

An Evaluation of Dose-escalation for Intrathoracic Tumours

NCT06794125

Conditions
Lung Cancers, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • British Columbia Cancer Agency Center for the Southern Interior Kelowna, British Columbia, Canada
  • London Health Sciences Center Research Institute (Formerly Lawson Research Institute) London, Ontario, Canada
  • Waterloo Regional Health Network Waterloo, Ontario, Canada
  • Horizon Health New Brunswick Saint John, New Brunswick, Canada
View Trial Details
Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

NCT06303505

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +22 more
Locations
  • The University of Alabama Birmingham, Alabama, United States
  • Mount Sinai New York, United States
  • Christ Hospital Cincinnati, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 29 locations
View Trial Details
Recruiting

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

NCT07489066

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +17 more
Locations
  • Hope and Healing Clinical Research Hinsdale, Illinois, United States
  • Hope and Healing Clinical Research New Lenox, Illinois, United States
  • Pan American Center for Oncology Trials, LLC - Manati Office Manati, Puerto Rico
  • Clearview Cancer Institute (Crestwood) Huntsville, Alabama, United States
View all 27 locations
View Trial Details
Recruiting

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06236438

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Hospital West /ID# 262221 Pembroke Pines, Florida, United States
  • Bond Clinic /ID# 262611 Winter Haven, Florida, United States
  • The University of Chicago Medical Center /ID# 262259 Chicago, Illinois, United States
  • University of Kansas Medical Center /ID# 263196 Westwood, Kansas, United States
View all 61 locations
View Trial Details

Related conditions